Benzodiazepine use declines across the US, led by reductions in older adults

Benzodiazepine treatment declined among U.S. adults between 2018 and 2022, with the steepest drop among adults ages 56 and older, according to a new study by researchers at the Columbia University Mailman School of Public Health and Columbia…

Continue Reading

News Source: medicalxpress.com